Latest News
SickKids Scientist Dr. Adam Shlien Secures $6 Million To Advance Cancer Diagnostic Platform
SickKids Scientist Dr. Adam Shlien Secures $6 Million To Advance Cancer Diagnostic Platform Dr. Adam Shlien, a Senior Scientist in the Genetics & Genome Biology program [...]
Exploring Immune Responses in Type One Diabetes Onset
Exploring Immune Responses in Type One Diabetes Onset Research led by Dr. Jayne Danska, Senior Scientist in the Genetics and Genome Biology program at The Hospital for [...]
Radiant Biotherapeutics Secures $2M Grant for Next-Gen HIV Biologics
Radiant Biotherapeutics Secures $2M Grant for Next-Gen HIV Biologics Industry Partnerships & Commercialization (IP&C) at The Hospital for Sick Children (SickKids) is pleased to share that [...]
Accelerating Innovation: IP&C’s Eighth Annual Proof of Principle Competition Awards $300,000 to Outstanding SickKids’ Projects
Accelerating Innovation: IP&C's Eighth Annual Proof of Principle Competition Awards $300,000 to Outstanding SickKids' Projects From exploring innovative approaches for epilepsy treatment, to introducing a device [...]
A designer peptide against the EAG2–Kvβ2 potassium channel targets the interaction of cancer cells and neurons to treat glioblastoma
Breaking new ground in glioblastoma research: A designer peptide against the EAG2–Kvβ2 potassium channel targets the interaction of cancer cells and neurons to treat glioblastoma Years [...]
A multi-specific, multi-affinity antibody platform neutralizes sarbecoviruses and confers protection against SARS-CoV-2 in vivo
A multi-specific, multi-affinity antibody platform neutralizes sarbecoviruses and confers protection against SARS-CoV-2 in vivo Researchers at The Hospital for Sick Children (SickKids) have developed a novel antibody [...]
Radiant Biotherapeutics Emerges from Stealth Mode with $8 Million Seed Round and Two Pharma Partnerships
Radiant Biotherapeutics Emerges from Stealth Mode with $8 Million Seed Round and Two Pharma Partnerships Radiant Biotherapeutics, a revolutionary antibody platform company developing multi-valent, multi-specific therapeutics [...]
Novel machine-learning algorithm creates atlas of cancer with potential as universal diagnostic platform
Novel machine-learning algorithm creates atlas of cancer with potential as universal diagnostic platform In the first broad comparison of paediatric and adult cancer, researchers at The [...]
Researchers develop novel algorithm to unlock role of cellular phenomenon in aggressive cancers
Researchers develop novel algorithm to unlock role of cellular phenomenon in aggressive cancers Scientists at The Hospital for Sick Children (SickKids) have developed a novel computational [...]
Seventh annual SickKids gap funding competition advances health-care innovations
Seventh annual SickKids gap funding competition advances health-care innovations From potential treatments for Clostridium difficile infection and medulloblastoma to a new way to standardize pain behaviour [...]
